Syndax Pharmaceuticals Statistics
Total Valuation
SNDX has a market cap or net worth of $2.02 billion. The enterprise value is $2.00 billion.
| Market Cap | 2.02B |
| Enterprise Value | 2.00B |
Important Dates
The next estimated earnings date is Friday, July 31, 2026, after market close.
| Earnings Date | Jul 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SNDX has 88.61 million shares outstanding. The number of shares has increased by 1.50% in one year.
| Current Share Class | 88.61M |
| Shares Outstanding | 88.61M |
| Shares Change (YoY) | +1.50% |
| Shares Change (QoQ) | +1.03% |
| Owned by Insiders (%) | 1.07% |
| Owned by Institutions (%) | 105.61% |
| Float | 79.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.30 |
| Forward PS | n/a |
| PB Ratio | 48.50 |
| P/TBV Ratio | 48.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.47, with a Debt / Equity ratio of 8.30.
| Current Ratio | 5.47 |
| Quick Ratio | 4.90 |
| Debt / Equity | 8.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.95 |
Financial Efficiency
Return on equity (ROE) is -189.53% and return on invested capital (ROIC) is -29.52%.
| Return on Equity (ROE) | -189.53% |
| Return on Assets (ROA) | -25.12% |
| Return on Invested Capital (ROIC) | -29.52% |
| Return on Capital Employed (ROCE) | -57.90% |
| Weighted Average Cost of Capital (WACC) | 6.62% |
| Revenue Per Employee | $728,772 |
| Profits Per Employee | -$816,272 |
| Employee Count | 298 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 10.45 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +146.49% in the last 52 weeks. The beta is 0.37, so SNDX's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | +146.49% |
| 50-Day Moving Average | 20.38 |
| 200-Day Moving Average | 20.12 |
| Relative Strength Index (RSI) | 56.44 |
| Average Volume (20 Days) | 2,299,570 |
Short Selling Information
The latest short interest is 21.81 million, so 24.62% of the outstanding shares have been sold short.
| Short Interest | 21.81M |
| Short Previous Month | 19.86M |
| Short % of Shares Out | 24.62% |
| Short % of Float | 27.40% |
| Short Ratio (days to cover) | 9.13 |
Income Statement
In the last 12 months, SNDX had revenue of $217.17 million and -$243.25 million in losses. Loss per share was -$2.79.
| Revenue | 217.17M |
| Gross Profit | -50.33M |
| Operating Income | -223.78M |
| Pretax Income | -243.25M |
| Net Income | -243.25M |
| EBITDA | -223.77M |
| EBIT | -223.78M |
| Loss Per Share | -$2.79 |
Balance Sheet
The company has $361.24 million in cash and $345.36 million in debt, with a net cash position of $15.88 million or $0.18 per share.
| Cash & Cash Equivalents | 361.24M |
| Total Debt | 345.36M |
| Net Cash | 15.88M |
| Net Cash Per Share | $0.18 |
| Equity (Book Value) | 41.62M |
| Book Value Per Share | 0.47 |
| Working Capital | 385.00M |
Cash Flow
In the last 12 months, operating cash flow was -$278.16 million and capital expenditures -$187,000, giving a free cash flow of -$278.35 million.
| Operating Cash Flow | -278.16M |
| Capital Expenditures | -187,000 |
| Depreciation & Amortization | 8,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -278.35M |
| FCF Per Share | -$3.14 |
Margins
Gross margin is -23.17%, with operating and profit margins of -103.04% and -112.01%.
| Gross Margin | -23.17% |
| Operating Margin | -103.04% |
| Pretax Margin | -112.01% |
| Profit Margin | -112.01% |
| EBITDA Margin | -103.04% |
| EBIT Margin | -103.04% |
| FCF Margin | n/a |
Dividends & Yields
SNDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.50% |
| Shareholder Yield | -1.50% |
| Earnings Yield | -12.04% |
| FCF Yield | -13.78% |
Analyst Forecast
The average price target for SNDX is $39.00, which is 71.05% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $39.00 |
| Price Target Difference | 71.05% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 58.31% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SNDX has an Altman Z-Score of -2.81 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.81 |
| Piotroski F-Score | 2 |